抑制NF-κB激活途径治疗IBD的进展

被引:2
作者
陈佳婕
钟良
机构
[1] 复旦大学附属华山医院消化科
关键词
炎症性肠病; 抑制; 核因子-κB; 药物治疗;
D O I
暂无
中图分类号
R574 [肠疾病];
学科分类号
1002 ; 100201 ;
摘要
IBD患者肠道黏膜免疫反应异常,NF-κB是参与调控肠道免疫炎性反应的关键因子之一。现已证明,多种IBD临床治疗用药,如糖皮质激素、5-氨基水杨酸、抑制性细胞因子等的药理作用均与抑制NF-κB激活途径有关。此文从NF-κB在IBD发病机制上的作用入手,总结了目前在营养素治疗、激素治疗、中药治疗及其他新药对抑制NF-κB激活途径治疗IBD的研究。
引用
收藏
页码:65 / 67
页数:3
相关论文
共 10 条
[1]  
炎症性肠病特殊营养素的补充[J]. 陈焰,姒健敏.世界华人消化杂志. 2005(13)
[2]   姜黄素调节小鼠免疫功能的实验研究 [J].
李新建 ;
刘晓城 .
中国组织化学与细胞化学杂志, 2005, (02) :132-135
[3]  
褪黑素对结肠炎大鼠免疫功能的影响[J]. 梅俏,于皆平,许建明,项立.世界华人消化杂志. 2002(02)
[4]  
Inhibition of lipopolysaccharide-induced release of interleukin-8 from intestinal epithelial cells by SMA, a novel inhibitor of sphingomyelinase and its therapeutic effect on dextran sulphate sodium-induced colitis in mice[J] . Akira Sakata,Kazuya Yasuda,Takashi Ochiai,Hiroshi Shimeno,Sadao Hikishima,Tsutomu Yokomatsu,Shiroshi Shibuya,Shinji Soeda.Cellular Immunology . 2007 (1)
[5]   Effects of the probiotic formulation VSL#3 on colitis in weanling rats [J].
Fitzpatrick, Leo R. ;
Hertzog, Kristy L. ;
Quatse, Angela L. ;
Koltun, Walter A. ;
Small, Jeffrey S. ;
Vrana, Kent .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 (05) :561-570
[6]  
The effect of heme oxygenase-1 induction by glutamine on TNBS-induced colitis[J] . International Journal of Colorectal Disease . 2007 (6)
[7]   Melatonin modulates signal transduction pathways and apoptosis in experimental colitis [J].
Mazzon, Emanuela ;
Esposito, Emanuela ;
Crisafulli, Concetta ;
Riccardi, Luisa ;
Muia, Carmelo ;
Di Bella, Paolo ;
Meli, Rosaria ;
Cuzzocrea, Salvatore .
JOURNAL OF PINEAL RESEARCH, 2006, 41 (04) :363-373
[8]   Zinc L-carnosine protects colonic mucosal injury through induction of heat shock protein 72 and suppression of NF-κB activation [J].
Odashima, Masaru ;
Otaka, Michiro ;
Jin, Mario ;
Wada, Isao ;
Horikawa, Youhei ;
Matsuhashi, Tamotsu ;
Ohba, Reina ;
Hatakeyama, Natsumi ;
Oyake, Jinko ;
Watanabe, Sumio .
LIFE SCIENCES, 2006, 79 (24) :2245-2250
[9]  
Blockade of NF- κ B Activation and Donation of Nitric Oxide: New Treatment Options in Inflammatory Bowel Disease?[J] . G. Dijkstra,H. Moshage,P. L. M. Jansen.Scandinavian Journal of Gastroenterology . 2002 (236)
[10]   Abnormal activation of transcription factor NF-κB involved in steroid resistance in chronic inflammatory bowel disease [J].
Bantel, H ;
Domschke, W ;
Schulze-Osthoff, K ;
Kaskas, B ;
Gregor, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (07) :1845-1846